Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 6/20 | 0.83 |
| ▸ | ESR1 | P03372 | 5/20 | 0.83 |
| ▸ | TTR | P02766 | 1/20 | 0.83 |
| ▸ | ALOX15 | P16050 | 7/20 | 0.62 |
| ▸ | ALOX12 | P18054 | 6/20 | 0.62 |
| ▸ | ALOX15B | O15296 | 3/20 | 0.62 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | RARA | P10276 | 1/20 | 0.44 |
| ▸ | RARB | P10826 | 1/20 | 0.44 |
| ▸ | RARG | P13631 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | GLA | P06280 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19861143 | 1.00 | ESR2 (0.83) | ESR2ESR1TTRALOX15ALOX12 | |
| SCHEMBL31545730 | 1.00 | ESR2 (0.83) | ESR2ESR1TTRALOX15ALOX12 | |
| Aus-131 SCHEMBL29005767 | 0.92 | ESR2 (0.79) | ESR2ESR1TTRALOX15ALOX12 | |
| Aus-131 SCHEMBL29005768 | 0.92 | ESR2 (0.79) | ESR2ESR1TTRALOX15ALOX12 | |
| Aus-131 SCHEMBL29005752 | 0.92 | ESR2 (0.79) | ESR2ESR1TTRALOX15ALOX12 | |
| SCHEMBL17565590 | 0.91 | ESR2 (0.78) | ESR2ESR1TTRALOX15ALOX12 | |
| Aus-131 SCHEMBL677723 | 0.91 | ESR2 (1.00) | ESR2ESR1TTRALOX15ALOX12 | |
| Aus-131 SCHEMBL43648 | 0.91 | ESR2 (1.00) | ESR2ESR1TTRALOX15ALOX12 | |
| Aus-131 SCHEMBL29467332 | 0.91 | ESR2 (1.00) | ESR2ESR1TTRALOX15ALOX12 | |
| Aus-131 SCHEMBL2002128 | 0.91 | ESR2 (1.00) | ESR2ESR1TTRALOX15ALOX12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250090554-A1 | A METHOD OF TREATING DEPRESSION BY IMMUNE MODULATION | MYND LIFE SCIENCES INC (CA) | 2025-03-20 | — | — | US | disclosed |
| US-9914718-B2 | Anhydrous crystalline form of S-equol | AUSIO PHARMACEUTICALS, LLC (US) | 2018-03-13 | — | — | US | disclosed |
| US-20160102070-A1 | ANHYDROUS CRYSTALLINE FORM OF S-EQUOL | AUSIO PHARMACEUTICALS, LLC (US) | 2016-04-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160102070-A1 | ANHYDROUS CRYSTALLINE FORM OF S-EQUOL | SULT2A1, SULT1E1, SULT1A1 | ESR2 157/4885ESR1 94/4885TTR 747/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.